Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Hisky Medical

Request full access

Hisky focuses on non-invasive disease diagnosis technologies and develops FibroTouch

Haidian, ChinaFounded 2010Health Tech & Medtech

About Hisky Medical

Hisky Medical Technologies, established in 2010, is a high-tech medical equipment company operating in the diagnostic equipment industry. The company was founded by three doctoral graduates from Tsinghua University: Shao Jinhua, Sun Jin, and Duan Houli. Their complementary backgrounds in biomedical engineering and automation led them to identify the potential of Tsinghua University's transient elastography technology for the early diagnosis of liver disease, a concept they decided to commercialize in 2008. The firm's establishment in Wuxi was influenced by favorable local government policies and a supportive investment environment.

Hisky Medical develops, manufactures, and markets non-invasive medical devices designed for the diagnosis and monitoring of liver diseases. The company's business model is centered on the sale of these high-tech medical devices to its primary clients: hospitals and medical institutions. Headquartered in Wuxi, China, with additional R&D centers in Beijing, Hisky has secured significant venture capital, including a Series D funding round of $13.7M in January 2025, bringing its total funding to $45.2M.

The company's flagship product is the FibroTouch system, a non-invasive device for diagnosing liver fibrosis and steatosis. It utilizes transient elastography (TE) technology, which measures the speed of a low-frequency shear wave (50Hz) propagating through liver tissue to determine its stiffness, a key indicator of fibrosis. This method assesses a liver tissue volume approximately 100 times larger than a traditional biopsy, offering a more comprehensive analysis without the risks and discomfort of invasive procedures. The system also measures the Ultrasound Attenuation Parameter (UAP) to quantify hepatic steatosis (fatty liver). A key feature is its single dynamic probe, designed to be effective for a wide range of patients, including children and obese individuals, which distinguishes it from some competitors. The product line, which includes the iLivTouch series, has received certifications such as the EU's CE mark (2014) and U.S. FDA approval (2018), allowing for its sale in international markets.

Source: Dealroom company data

At a glance

Status
Operational
Employees
5
Open positions
None listed
Dealroom signal
34.7/100
Industry
Health
Sub-industry
Medical Devices
Sector
Non-Invasive medical devices and treatments, Health Diagnostics, Ultrasound Sensors, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES D✓Equity / VC Mar 2025 $14M $55M Hunan High-tech Venture Capital · River Head Capital · Guoju Venture Capital ↗
SERIES BEquity / VC Aug 2021 $14M $55M Kunpeng Capital ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Hisky Medical website traffic

Latest recorded traffic for Hisky Medical is 620 monthly website visits, up 34.8% over the last three months. Hisky Medical's team declined 16.7% over the past year.

Latest monthly visits620 3-month web change+34.8% 1-year team growth-16.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Hisky Medical in the Haidian ecosystem

Live from Dealroom

The Hisky Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Series B and later3 investors entered at this stage

  • River Head Capital
  • Hunan High-tech Venture Capital
  • Guoju Venture Capital

Other known investors1 additional known investor

  • Pitch@Palace
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇨🇳 China66.7%
🇮🇳 India33.3%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Hisky Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Hisky Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.